Article List

WPRIM Management System> DCMS> Journal of Experimental Hematology> 2016> 24> 1

Volume: 24 Issue: 1

1. Research Advances on Targeted Therapy for Acute Myeloid Leukemia--Review.	Page:245—249
2. Neutrophil CD64 Expression as A Biomarker in the Early Diagnosis of Sepsis in Malignant Hematologic Disease--Review.	Page:241—244
3. Research Progress on Long Non-Coding RNA in Hematological Malignancies--Review.	Page:237—240
4. Role of SOX7 in Hematopoietic System Development and Hematological Malignancies--Review.	Page:233—236
5. Establishment of Method for Detecting Red Blood Cell Osmotic Fragility by Flow Cytometry.	Page:229—232
6. Genetic Indentification of An Individual with A102Bw33 Blood Group Gene Subtypes of ABO Variant.	Page:225—228
7. Study on Serological Blood Group Conversion in BM Empty Phase of ABO-incompatible Allogeneic Stem Cell Transplantation.	Page:221—224
8. Comparison of the Intrab-batch Precisions and Results of 4 Tests by 2 Operation Modes of SysmexCA-7000 Blood Coagulometer.	Page:217—220
9. Effect of Intercellular Adhesion Molecule-1 on Adherence Between Mesenchymal Stem Cells and Endothelial Progenitor Cells.	Page:211—216
10. Relationship among the Oxygen Concentration, Reactive Oxygen Species and the Biological Characteristics of Mouse Bone Marrow Hematopoietic Stem Cells.	Page:205—210
11. Inducing Effect of Modified Cytokine Cocktail on Dendritic Cells.	Page:197—204
12. Effects of Leukemia Inhibitory Factor Combined with Basic Fibroblast Growth Factor on Self-maintenance and Self-renewal of Human Umbilical Cord Mesenchymal Stem Cells In Vitro.	Page:184—190
13. Mesenchymal Stem Cells Combined with Budesonide, Almeterol and Azithromycin for the Treatment of Bronchiolitis Obliterans Syndrome after Hematopoietic Stem Cell Transplantation.	Page:173—177
14. Gene Analysis of Thalassemia in Han and Dai Ethnic Childbearing-aged Population of Chinese Yunnan Province.	Page:150—156
15. Effect of Artesunate on Proliferation, Cell Cycle and Apoptosis of SKM-1 Cells and Its Underlying Mechanisms.	Page:131—137
16. Clinical Efficacy of Dendritic Cells and Cytokine-induced Killer Cells Combined with Chemotherapy for Treating Newly diagnosed Multiple Myeloma and their Effect on Function of CD4(+) CD25(+) T Cells in Peripheral Blood.	Page:122—126
17. HSP90 Inhibitor 17-AAG Inhibits Multiple Myeloma Cell Proliferation by Down-regulating Wnt/β-Catenin Signaling Pathway.	Page:117—121
18. Clinical Significance of P53, C-MYC and BCL-6 Abnormality in Patients with Diffuse Large B Cell Lymphoma.	Page:89—93
19. Clinical Efficacy Comparison between CHOPE Regimen alone and It Combined with Thalidomide for Relapsed and Refractory Non-Hodgkin's Lymphoma.	Page:84—88
20. Clinical Efficacy for Treatment of Patients with Peripheral T Cell Lymphoma by HyperCVAD and CHOP/CHOP-like Protocols.	Page:80—83
21. Effect of Rapamycin on Expression of Survivin and Caspase-3 and Its Influence on K562 Cell Ultrastructure.	Page:52—55
22. Overexpression of SHP-1 Enhances the Sensitivity of K562 Cells to Imatinib.	Page:46—51
23. Effect of Silencing SET Gene on Acute Promyelocytic Leukemia NB4-R1 Cells.	Page:41—45
24. Acadesine Inhibits the Proliferation of K562 Cells and Enhances their Sensitivity to Imatinib.	Page:36—40
25. Influence of L-asaraginase and Pegaspargase on Coagulation Function of Adult Patients with Acute Lymphoblastic Leukemia and Analysis of Related Factors.	Page:30—35
26. Clinical Efficacy and Safety of Rituximab Combined with Fludarabine and Cyclophosphamide for Treatment of Chronic Lymphocytic Leukemia.	Page:25—29
27. Clinic Outcome of FLAG Regimen treating Patients with Refractory and Relapse Acute Myeloid Leukemia.	Page:19—24
28. Retrospective Analysis of the Impact of Treatment on Prognosis in 44 Adolescents and Young Adult Patients with Acute Lymphoblastic Leukemia.	Page:14—18
29. Effect of Emodin Derivative E11 on T Lymphocytic Leukemia Cell Line Molt-4 and Its Possible Mechanisms.	Page:8—13
30. Effect of A Novel Emodin Derivative on Chronic Myelogenous Leukemia K562 Cells and Imatinib-resistant K562/G01 Cells.	Page:1—7
31. Comparison of Several Optimization Schemes for the Induction and Expansion of Antibody-Mediated High Efficiency CIK (AMHE-CIK) In Vitro.	Page:191—196
32. Effect of Human Umbilical Cord Mesenchymal Stem Cells on Etoposide-induced Nalm-6 Cell Apoptosis.	Page:178—183
33. Clinical Significance of Monitoring T Lymphocyte Subsets after Allogeneic Hematopoietic Stem Cell Transplantation.	Page:167—172
34. Rituximab and Dexamethasone Combined with Cyclophosphamide for Treatment of Relapsed and Refractory Immune Thrombocytopenia.	Page:162—166
35. Gene Mutation Spectrum of β-Thalassemia in Dai Ethinic Population of Two Border Region in Chinese Yunnan Province.	Page:157—161
36. Effect of Dexamethasone on Blast Composition in Patients with Myelodysplastic Syndrome and Its Diagnostic Significance.	Page:144—149
37. Significance of Morphological Examination, Cytochemical Staining Combined with Bone Marrow Biopsy in Differential Diagnosis of Myelodysplastic Syndrome with Low Blasts and Hemolytic Anemia.	Page:138—143
38. Cytogenetic Abnormalities and Outcomes of 117 Patients with Multiple Myeloma Detected by FISH.	Page:127—130
39. Inductive Effect of 5-Azacitidine on Apoptosis of Multiple Myeloma Cell lines and Its Mechanism.	Page:110—116
40. Evaluation Value of Invasion Area PET-CT Scanning for Chemotherapeutic Efficacy and Prognosis of Patients with Lymphoma.	Page:106—109
41. Value of Multiparameter Flow Cytometry in Diagnosis of Non-Hodgkin's Lymphoma.	Page:102—105
42. Clinical Significance of Detecting CyclinD1 and BCL-2 in Patients with B-Cell Lymphoma by Using Flow Cytometry.	Page:98—101
43. Clinical Value of Immunophenotype Detection and DNA Ploid Analysis by Flow Cytometry for Non-Hodgkin's Lymphoma Patients.	Page:94—97
44. Clinical and Prognostic analysis of 43 Children with Mature B-cell Non-Hodgkin's Lymphoma/Acute Lymphoblastic Leukemia.	Page:72—79
45. Influence of Mouse Spleen Microenviroment on T-ALL Progression.	Page:66—71
46. Methylation of miR-378 in Chronic Myeloid Leukemia.	Page:61—65
47. Effect of Decitabine on DKK1 Gene Demethylation in Leukemia Cells.	Page:56—60
48. Bone Marrow Microenvironment and Myelodysplastic Syndromes--Review.	Page:290—294
49. Molecular Markers of Prognosis in Myelodysplastic Syndromes--Review.	Page:285—289
50. Significance of ST2 in the Early Diagnosis and Treatment of Graft-Versus-Host Disease--Review.	Page:307—310
51. Research Progres on Relationship between the Graft-Versus-Host Disease and Cytomegalovirus Infection--Review.	Page:303—306
52. Recent Advances on the Immunoregulation of MicroRNA-155 in Mesenchymal Stem Cells--Review.	Page:299—302
53. Research Advances of A New Co-stimulatory Molecule-B7 Homolog 6--Review.	Page:295—298
54. CAR Technology and Its Application in Treatment of Multiple Myeloma--Review.	Page:279—284
55. Research Advances on Treatment of Multiple Myeloma Bone Disease--Review.	Page:275—278
56. Research Advances on Extranodal Nasal Type NK/T Cell Lymphoma--Review.	Page:271—274
57. Therapy-related Virus Reactivation in Lymphoma Patients with Hepatitis B Virus Infection--Review.	Page:266—270
58. Research Progress on Drug-resistance of Acute Lymphoblastic Leukemia--Review.	Page:261—265
59. Large Granular Lymphocytic Leukemia and JAK/STAT Signaling Pathway--Review.	Page:254—260
60. One of the Mechanisms in Blastic Transformation of Chronic Myeloid Leukemia: Epigenetics Abnormality--Review.	Page:250—253